Elanco
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.About ELAN
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior.
ELAN Key Statistics
Stock Snapshot
Elanco(ELAN) stock is priced at $21.29, giving the company a market capitalization of 10.58B. It carries a P/E multiple of 292.04.
On 2025-12-14, Elanco(ELAN) stock moved within a range of $20.97 to $21.49. With shares now at $21.29, the stock is trading +1.6% above its intraday low and -0.9% below the session's peak.
Trading activity shows a volume of 5.34M, compared to an average daily volume of 5.82M.
Over the past 52 weeks, Elanco(ELAN) stock has traded between a high of $23.70 and a low of $8.02.
Over the past 52 weeks, Elanco(ELAN) stock has traded between a high of $23.70 and a low of $8.02.
ELAN News
On Tuesday, Elanco Animal Health Incorporated (NYSE:ELAN) used its first Investor Day in five years to signal a turning point for the company, outlining a more...
In conjunction with its Investor Day on Tuesday, Elanco Animal Health (ELAN) announced plans to eliminate hundreds of jobs as part of a cost-cutting program tar...
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Analyst ratings
78%
of 18 ratingsMore ELAN News
Elanco (ELAN) hosted its first Investor Day in five years. Elanco detailed its Innovation, Portfolio and Productivity, or IPP, strategy aimed at guiding the com...
Elanco (ELAN) will implement organizational changes designed to generate approximately $25M and $60M in savings in 2026 and 2027, respectively, as part of its E...
Technology How Protein And Pets Drove Elanco Animal Health's 79% Gain In 2025 Licensing Move aside, Impossible Burger. Animal protein is roaring back with a ven...